Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-11-25Establishing a Clinical Database and Biobank for Schizophrenia：A Cohort Study
-
CLINICAL_TRIALS study record update · 2024-11-21Effects of Music Beat on Motor Function in Individuals At Risk for Psychotic Onset and Schizophrenia Patients
-
CLINICAL_TRIALS study record update · 2024-11-19A Randomized, Double-blinded, Placebo-controlled Study of Rituximab in Patients with Psychosis And/or Obsessive Compulsive Disorder, with an Indication of Immune System Involvement
-
CLINICAL_TRIALS study record update · 2024-11-15Chronical Illness-related Limitations of the Ability to Cope with Rising Temperatures: an Observational Study, Second Wave (CLIMATE-II)
-
CLINICAL_TRIALS study record update · 2024-11-13A Qualitative Study of Service User and Staff Views on Digital Remote Monitoring for Unusual Distressing Experiences (psychosis)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-11-12Muscarinic M1 Receptor Availability and Cognition in Schizophrenia
-
CLINICAL_TRIALS study record update · 2024-11-12A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment in Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2024-11-08Mobile-assisted Cognitive Behavioral Therapy for Negative Symptoms in Schizophrenia: An RCT
-
CLINICAL_TRIALS study record update · 2024-11-08Mobile-Assisted Cognitive Behavior Therapy for Negative Symptoms in Schizophrenia
-
CLINICAL_TRIALS study record update · 2024-11-07A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Lumateperone for the Prevention of Relapse in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2024-11-07Automatic Measurement of Antipsychotic Medication Adherence in Schizophrenia Through Speech (OBSERVSPEECH)
-
CLINICAL_TRIALS study record update · 2024-10-31A Phase 1 Randomized, 2-way, Crossover Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2024-10-31A Phase 1 Multiple Ascending Oral Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2024-10-30A Multicenter, Uncontrolled, Open-label Trial to Investigate the Long-term Tolerability, Safety, and Efficacy of Brexpiprazole Once-weekly (QW) Formulation Administered Once Weekly for 52 Weeks in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2024-10-28Safety, Tolerability, and Treatment Response of Paliperidone Palmitate in Subjects With Schizophrenia When Switching From Oral Antipsychotics
-
CLINICAL_TRIALS study record update · 2024-10-28An Open-label Extension Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Subjects With DSM-5 Schizophrenia
-
CLINICAL_TRIALS study record update · 2024-10-28An Open-Label, Prospective, Non-Comparative Study to Evaluate the Efficacy and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia
-
CLINICAL_TRIALS study record update · 2024-10-24A Study on the Preference of Risperidone Dosage Forms
-
CLINICAL_TRIALS study record update · 2024-10-24A Multi Dose, Open-Label, Parallel-Group Study to Evaluate the PK and Safety/Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective Disorder
-
CLINICAL_TRIALS study record update · 2024-10-22NST-SPARK: Preliminary Study of an Augmented Reality (AR) App Delivering Recovery-Oriented Cognitive Therapy for Negative Symptoms in Schizophrenia
-
CLINICAL_TRIALS study record update · 2024-10-21The Switch Study - Efficacy of Early Antipsychotic Switch Versus Maintenance in Patients With Schizophrenia Poorly Responding to Two Weeks of Antipsychotic Treatment
-
CLINICAL_TRIALS study record update · 2024-10-21A Randomized, Double-blind, Double-dummy, Positive Drug Parallel Controlled Phase III Clinical Study to Evaluate the Safety and Efficacy of Olanzapine-Samidorphan Tablets in Adults With Schizophrenia
-
CLINICAL_TRIALS study record update · 2024-10-15HDAC Inhibitor Augmentation to Clozapine
-
CLINICAL_TRIALS study record update · 2024-10-08Adjunctive Withania Somnifera (Ashwagandha) for Persistent Symptoms in People With Schizophrenia
-
CLINICAL_TRIALS study record update · 2024-10-04A Placebo-Controlled Study to Evaluate the Effect of a Single Dose of CVN058 on Mismatch Negativity in Subjects With Stable Schizophrenia